Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism SOD3 modulators(Superoxide dismutase 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | US | 29 Nov 2018 | |
Brain Injuries, Traumatic | Discovery | US | 02 Aug 2021 |